Language | Title | Revision | Published | Download PDF | Change history | Printed copy |
---|
Error! A problem has occurred while submitting your data.
The BIOTRONIK Vascular Intervention business, with the exception of IMDS products, has been acquired by Teleflex, effective as of July 1st, 2025. These products are now part of the Teleflex portfolio. For questions or further information relating to the Vascular Intervention portfolio, please complete the contact form.
Contact
Contact
California Proposition 65
Note:
This product can expose you to chemicals including ethylene oxide,
which is known to cause cancer and birth defects or other
reproductive harm.
For more information, go to: www.P65Warnings.ca.gov.